## PH: Parker-Hannifin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 1.6% below STRENGTH zone (4.0-10.0%); PEG 4.91 fails VALUE criteria (<1.0); RSI 71 overbought. Stock is in no-man's land without clear edge. Caution: declining volume (56% of avg), momentum weakening (-2.6% MRS), overbought RSI (71).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($833.52)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Parker Hannifin stock reaches all-time high at 869.48 USD By Investing.com**
- Source: Investing.com Nigeria | 20251203T224800 | Bullish | Relevance: 100%
- Parker Hannifin Corporation's stock has hit an all-time high of $869.48, reflecting significant year-to-date and past year growth. This milestone is supported by strong demand, a "GREAT" financial health score, and a 55-year history of consistent dividend payments, alongside a recent major acquisition of Filtration Group Corporation. The company's strategic initiatives and market capitalization efforts continue to boost investor confidence.

**2. Westerkirk Capital Inc. Invests $5.64 Million in Parker-Hannifin Corporation $PH**
- Source: MarketBeat | 20251203T141140 | Bullish | Relevance: 100%
- Westerkirk Capital Inc. has acquired a new stake of 8,070 shares in Parker-Hannifin Corporation (NYSE:PH) worth approximately $5.64 million during the second quarter. This investment comes as Parker-Hannifin reported strong Q3 earnings, beating estimates, and received a consensus "Moderate Buy" rating from analysts with an average price target of $860.71. The company also declared a quarterly dividend of $1.80, while institutional investors show high ownership and some insiders have recently sold shares.

**3. Here's Why You Should Consider Investing in Parker-Hannifin Now**
- Source: Finviz | 20251203T092700 | Bullish | Relevance: 100%
- Parker-Hannifin Corporation (PH) is presented as a strong investment due to its robust Aerospace segment and strategic acquisitions like Filtration Group Corp. and Curtis Instruments. The company's "Win Strategy" and commitment to returning value to shareholders through dividends and buybacks further enhance its investment appeal, with its stock performance already significantly outpacing the industry.

**4. How Strong Aerospace and Defense Growth Will Impact Parker-Hannifin (PH) Investors**
- Source: Simply Wall Street | 20251202T051537 | Bullish | Relevance: 100%
- Parker-Hannifin recently reported strong quarterly results, surpassing analyst expectations, driven by growth in aerospace and defense sectors, and a recovering industrial segment in North America. This performance has led to raised fiscal 2026 guidance, projecting sales growth between 4.0% and 7.0% and higher adjusted EPS, reflecting a positive investment outlook. However, investors are cautioned about potential risks from a sudden aerospace downturn or a slower-than-expected industrial recovery.

**5. Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War**
- Source: ts2.tech | 20251201T230446 | Somewhat-Bullish | Relevance: 100%
- This article provides a comprehensive outlook on Parker-Hannifin (PH) stock as of December 2025, highlighting its strong performance driven by aerospace growth, a record-breaking fiscal Q1 2026, and the strategic $9.25 billion acquisition of Filtration Group. It delves into the ongoing debate regarding its valuation, with some models suggesting overvaluation despite general Wall Street bullishness. The analysis covers financial snapshots, performance against the S&P 500, recent headlines, acquisition details, Q1 results, analyst ratings, and the key drivers and risks for 2026.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 7, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Baird | $960 | $930 | +3% |
| 2025-11-12 | Susquehanna | $1000 | $960 | +4% |
| 2025-11-10 | Argus Research | $900 | $0 | 0% |
| 2025-11-07 | Wells Fargo | $925 | $840 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Baird | main | Outperform |
| 2025-11-12 | Susquehanna | main | Positive |
| 2025-11-10 | Argus Research | reit | Buy |
| 2025-11-07 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 5 ($3.88M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.1%)
- Blackrock Inc.: 7.8% (+0.6%)
- State Street Corpora: 7.6% (-0.7%)
- Procyon Advisors, LL: 4.0% (+158565.8%)
- Bank of America Corp: 3.1% (+0.6%)

### Key Risks

1. Insider selling cluster: $3.9M in recent transactions.
2. Valuation stretched: PEG 4.9x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 7 raises (avg +9%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.91 signals overvaluation risk, limited margin of safety. Forward P/E 26.3x stretched relative to 9% growth. Quality metrics strong (ROE 27%, margin 18%). Analyst sentiment positive (7 raises, avg +9%). Insider selling cluster ($3.9M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $112.4B |
| Beta | 1.25 |
| 52W Range | $488.45 - $908.35 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.91 |
| Forward P/E | 26.3 |
| Current P/E | 28.7 |
| YoY Growth | 9.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.2% to 1.6% (-2.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.4pp (needs >4.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. AM_20 at 3.5% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.85), confirming momentum. RSI overbought at 71, risk of mean reversion. Volume at 56% of 20MA suggests lack of conviction. OFD pattern: +MLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.59% (CS: 68) | Neutral |
| RSI_14 | 70.9 | Overbought |
| MACD Histogram | 0.85 | Bullish |
| vs SMA20 | 1.035x | Above |
| vs SMA50 | 1.103x | Above |
| vs SMA200 | 1.237x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $869.20
- **Stop Loss:** $833.52 (4.1% risk)
- **Target:** $904.88 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 26
- **Position Value:** $22,599.20
- **Portfolio %:** 22.60%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-01-29 (Est: $7.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.62 | $7.22 | +9.0% |
| 2025Q2 | $7.08 | $7.69 | +8.6% |
| 2025Q1 | $6.72 | $6.94 | +3.3% |
| 2024Q4 | $6.23 | $6.53 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*